RALEIGH – The technology-enabled medical device services company Veranex, which has been on an acquisition binge this year, has switched up its executive suite.
According to a statement, the company has appointed Tom Daulton as the firm’s new CEO, while the prior CEO David Dockhorn will now fill the new role of chief operating officer.
Daulton previously served as the chairman and CEO of National Dentex Labs and has prior experience in other medical device and healthcare organizations, according to a company statement.
“The addition of Daulton will further expand extensive device experience across the Veranex executive suite,” the statement reads.
Daulton said in a statement that the company is “clearly poised for an exciting future.”
Looking back, looking ahead
In 2021, the company acquired six other firms, according to prior WRAL TechWire reporting. It would continue that acquisition binge into 2022, as well.
Earlier this month, Veranex announced it had acquired multiple Swedish firms, after previously buying a Swiss company.
According to a story written for WRAL TechWire, in 2021, the company paired up with investment firm Summit Partners to create a “soup-to-nuts service provider for the medical technology industry.”
The firm took on two strategic investments in May 2022.
In a statement, Daulton expressed confidence that he would lead the company and its acquired firms to a “powerful, unified business” by knitting a variety of cultures together as its new CEO.
Now, Dockhorn moves into a COO role that will enable him to “focus on operational excellence,” according to the company’s statement.
“I am proud of the company we are building and the impact we are making every day with our customers,” Dockhorn said. “I am excited to strengthen our impact by focusing on building the operational teams that support organic growth as we continue to build out our capabilities and enhance our operations, while Tom focuses on leading the organization and helping it expand.”